BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6126268)

  • 1. Calcitonin, somatostatin and ACTH immunoreactive cells in a case of familial bilateral thyroid medullary carcinoma.
    Charpin C; Andrac L; Monier-Faugere MC; Hassoun J; Cannoni M; Vagneur JP; Toga M
    Cancer; 1982 Nov; 50(9):1806-14. PubMed ID: 6126268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunohistochemical detection of calcitonin, ACTH, beta-MSH, beta-endorphin and somatostatin in medullary carcinoma of the thyroid. Immunoperoxidase study (PAP, ABC) of 10 cases].
    Charpin C; Argemi B; Cannoni M; Oliver C; Gillioz P; Vagneur JP; Toga M
    Ann Pathol; 1984; 4(1):27-35. PubMed ID: 6142718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
    Bethge N; Ahuja S; Diel F
    Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple endocrine cell types in thyroid medullary carcinoma. Evidence for calcitonin, somatostatin, ACTH, 5HT and small granule cells.
    Capella C; Bordi C; Monga G; Buffa R; Fontana P; Bonfanti S; Bussolati G; Solcia E
    Virchows Arch A Pathol Anat Histol; 1978 Feb; 377(2):111-28. PubMed ID: 205037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin-immunoreactive cells in medullary carcinoma of the thyroid.
    Sundler F; Alumets J; Håkanson R; Björklund L; Ljungberg O
    Am J Pathol; 1977 Aug; 88(2):381-6. PubMed ID: 195473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medullary thyroid carcinoma and calcitonin.
    Emmertsen K
    Dan Med Bull; 1985 Mar; 32(1):1-28. PubMed ID: 2859145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medullary differentiation of anaplastic thyroid carcinoma.
    Nieuwenhuijzen Kruseman AC; Bosman FT; van Bergen Henegouw JC; Cramer-Knijnenburg G; Brutel de la Riviere G
    Am J Clin Pathol; 1982 May; 77(5):541-7. PubMed ID: 6177234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A compound follicular-parafollicular cell carcinoma of the thyroid: a new tumor entity?
    Ljungberg O; Ericsson UB; Bondeson L; Thorell J
    Cancer; 1983 Sep; 52(6):1053-61. PubMed ID: 6136320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistological studies of medullary thyroid carcinoma and C cell hyperplasia.
    Deftos LJ; Bone HG; Parthemore JG
    J Clin Endocrinol Metab; 1980 Oct; 51(4):857-62. PubMed ID: 6106648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An efficient method to detect calcitonin mRNA in normal and neoplastic rat C-cells (medullary thyroid carcinoma) by in situ hybridization using a digoxigenin-labeled synthetic oligodeoxyribonucleotide probe.
    Le Guellec P; Dumas S; Volle GE; Pidoux E; Moukhtar MS; Treilhou-Lahille F
    J Histochem Cytochem; 1993 Mar; 41(3):389-95. PubMed ID: 8429201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin inhibits the pentagastrin-induced release of serum calcitonin in medullary carcinoma of the thyroid.
    Gordin A; Lamberg BA; Pelkonen R; Almqvist S
    Clin Endocrinol (Oxf); 1978 Apr; 8(4):289-93. PubMed ID: 647984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of gastrin releasing peptide by medullary carcinoma of the thyroid. An immunohistochemical study.
    Kameya T; Bessho T; Tsumuraya M; Yamaguchi K; Abe K; Shimosato Y; Yanaihara N
    Virchows Arch A Pathol Anat Histopathol; 1983; 401(1):99-107. PubMed ID: 6412451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medullary carcinoma of the thyroid. An immunocytochemical and histochemical study of 25 cases using eight separate markers.
    Sikri KL; Varndell IM; Hamid QA; Wilson BS; Kameya T; Ponder BA; Lloyd RV; Bloom SR; Polak JM
    Cancer; 1985 Nov; 56(10):2481-91. PubMed ID: 2412687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACTH and calcitonin secreting medullary carcinoma of the thyroid.
    Croughs RJ; Eastham WN; Hackeng WH; Schopman W; Feltkamp-Vroom TM; Dolman A; Hennemann G
    Clin Endocrinol (Oxf); 1972 Apr; 1(2):157-71. PubMed ID: 4352168
    [No Abstract]   [Full Text] [Related]  

  • 15. Occult medullary carcinoma of thyroid: an unusual clinical and pathologic presentation.
    White IL; Vimadalal SD; Catz B; Van de Velde R; LaGanga T
    Cancer; 1981 Mar; 47(6):1364-8. PubMed ID: 7226060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses.
    Redding AH; Levine SN; Fowler MR
    Thyroid; 2000 Oct; 10(10):919-22. PubMed ID: 11081258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
    Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
    Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medullary carcinoma of the thyroid as a cause of Cushing's syndrome: a case with ectopic adrenocorticotropin secretion characterized by double enzyme immunostaining.
    Hijazi YM; Nieman LK; Medeiros LJ
    Hum Pathol; 1992 May; 23(5):592-6. PubMed ID: 1568756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural study of thyroid medullary carcinoma.
    Kakudo K; Miyauchi A; Katayama S
    Acta Pathol Jpn; 1977 Sep; 27(5):605-22. PubMed ID: 201148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medullary carcinoma of the thyroid.
    Hollenberg CH
    Arch Otolaryngol; 1983 Feb; 109(2):103-5. PubMed ID: 6849663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.